联环药业：控股子公司获得苯磺酸氨氯地平片药品注册证书

Group 1 - The core point of the article is that Lianhuan Pharmaceutical (600513) announced the approval of a drug registration certificate for Amlodipine Besylate Tablets by the National Medical Products Administration [1] Group 2 - The approved drug is Amlodipine Besylate Tablets, which is a medication used to treat high blood pressure and other cardiovascular conditions [1]